Triplet Therapeutics
ID: 6343839A therapeutics company developing siRNA and ASO therapeutics that target repeat expansion disorders such as Huntington’s disease, myotonic dystrophy and spinocerebellar ataxias
1
Funding Rounds
$59.0m
Money raised
Recent Funding Rounds
Overview
A therapeutics company developing siRNA and ASO therapeutics that target repeat expansion disorders such as Huntington’s disease, myotonic dystrophy and spinocerebellar ataxias
- Website:
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ne**** Be******** |
|
- |
Funding series
Funding Series Analysis
The company Triplet Therapeutics has raised a total of $59m in funding over 1 rounds.
Key Insights:
- Tripley Therapeutics Series A round, December 2019: $59m
Industries
Triplet Therapeutics is active in the following industries: